News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Process characterization is an important step in the product development journey. Download this Q&A article to learn the latest trends, status, and insights into process characterization and validation of monoclonal antibodies and recombinant proteins.
Process characterization and validation is an important step in the product development journey and late-phase development, and it is required before transferring an existing manufacturing process.
Deliver safe and stable products to your patients with the help of Catalent Biologics' Limoges, France site, a European Center of Excellence for early-phase clinical biologics formulation development and drug product fill/finish. It offers an integrated...
For more product information visit Catalent.